A detailed history of Rhumbline Advisers transactions in Smith & Nephew PLC stock. As of the latest transaction made, Rhumbline Advisers holds 11,210 shares of SNN stock, worth $281,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,210
Previous 10,365 8.15%
Holding current value
$281,931
Previous $256,000 36.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$24.51 - $31.64 $20,710 - $26,735
845 Added 8.15%
11,210 $349,000
Q2 2024

Aug 01, 2024

BUY
$23.77 - $26.48 $19,467 - $21,687
819 Added 8.58%
10,365 $256,000
Q1 2024

May 09, 2024

BUY
$25.36 - $28.88 $41,641 - $47,420
1,642 Added 20.77%
9,546 $242,000
Q4 2023

Feb 08, 2024

SELL
$21.55 - $27.43 $1,293 - $1,645
-60 Reduced 0.75%
7,904 $215,000
Q3 2023

Nov 09, 2023

BUY
$24.33 - $31.28 $851 - $1,094
35 Added 0.44%
7,964 $197,000
Q2 2023

Aug 08, 2023

BUY
$28.08 - $32.7 $222,646 - $259,278
7,929 New
7,929 $255,000

Others Institutions Holding SNN

About SMITH & NEPHEW PLC


  • Ticker SNN
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 435,348,000
  • Market Cap $10.9B
  • Description
  • Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...
More about SNN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.